Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHA | AMGN | BMY | VRTX | GILD |
| Company | Innate Pharma S.A. ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.8000 | 269.33 | 56.13 | 415.13 | 91.35 |
| High | 1.8007 | 272.82 | 56.74 | 422.46 | 92.57 |
| Low | 1.7300 | 269.33 | 55.66 | 415.13 | 91.04 |
| Last | 1.7300 | 270.61 | 56.53 | 422.65 | 91.88 |
| Change | -0.0550 | +3.51 | +0.79 | +10.99 | +0.88 |
| % Change | -3.08% | +1.31% | +1.42% | +2.67% | +0.97% |
| Volume | 12,936 | 472,794 | 1,335,294 | 241,951 | 1,483,773 |
| 20-Day Average Volume | 100,829 | 3,465,678 | 10,989,576 | 2,012,343 | 6,148,720 |
| Previous Close | 1.7850 | 267.10 | 55.74 | 411.66 | 91.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9748 | 263.32 | 56.75 | 415.24 | 91.84 |
| 20-Day Raw Stochastic | 10.68% | 93.24% | 44.31% | 44.50% | 59.87% |
| 20-Day Relative Strength | 46.65% | 47.56% | 49.41% | 44.49% | 53.07% |
| Weighted Alpha | -60.09 | -14.67 | +18.09 | -7.69 | +15.89 |
| Today's Opinion | 56% Sell | 88% Sell | 40% Buy | 72% Sell | 80% Buy |
| Previous Opinion | 56% Sell | 88% Sell | 40% Buy | 88% Sell | 56% Buy |
| Last Month's Opinion | 96% Sell | 88% Sell | 80% Buy | 24% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.91% since 01/07/25 | +3.56% since 01/07/25 | -1.18% since 01/07/25 | +3.04% since 01/07/25 | +1.68% since 01/07/25 |
| Low | 1.6400 on 01/08/25 | 259.82 on 01/08/25 | 54.81 on 01/13/25 | 397.24 on 01/13/25 | 88.57 on 01/10/25 |
| High | 1.8700 on 01/13/25 | 272.64 on 01/15/25 | 57.05 on 01/08/25 | 420.99 on 01/15/25 | 92.57 on 01/15/25 |
| 1-Month | |||||
| %Chg | -42.05% since 12/13/24 | +0.28% since 12/13/24 | +1.23% since 12/13/24 | -9.27% since 12/13/24 | +0.32% since 12/13/24 |
| Low | 1.6400 on 01/08/25 | 253.30 on 12/19/24 | 54.81 on 01/13/25 | 377.85 on 12/19/24 | 88.57 on 01/10/25 |
| High | 2.6700 on 12/16/24 | 272.69 on 12/16/24 | 58.54 on 12/18/24 | 474.18 on 12/17/24 | 94.55 on 12/26/24 |
| 3-Month | |||||
| %Chg | -13.79% since 10/15/24 | -16.52% since 10/15/24 | +7.02% since 10/15/24 | -13.13% since 10/15/24 | +7.38% since 10/15/24 |
| Low | 1.2900 on 11/18/24 | 253.30 on 12/19/24 | 51.81 on 10/28/24 | 377.85 on 12/19/24 | 85.60 on 10/22/24 |
| High | 3.5107 on 12/13/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -17.45% since 07/15/24 | -17.80% since 07/15/24 | +40.64% since 07/15/24 | -14.29% since 07/15/24 | +30.14% since 07/15/24 |
| Low | 1.2900 on 11/18/24 | 253.30 on 12/19/24 | 40.09 on 07/16/24 | 377.85 on 12/19/24 | 70.33 on 07/16/24 |
| High | 3.5107 on 12/13/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 147,802 | 143,575,072 | 113,050,592 | 106,014,392 | 113,410,208 |
| Shares Outstanding, K | 82,802 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 66,710,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -8,190,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | N/A | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.27 | 0.56 | 0.45 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/13/24 | 02/04/25 | 02/06/25 | 02/03/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | N/A | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.06 | 47.32 | 0.00 | 20.30 |